Inventor
MALAVIYA RAVI
US15 patents
⚠️ This page may combine multiple inventors who share the name “MALAVIYA RAVI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PARKER HUGHES INST
7 patentsUS6753348B2Jun 22, 2004
BTK inhibitors and methods for their identification and use
PARKER HUGHES INST130 citations99
US6313130B1Nov 6, 2001
JAK-3 inhibitors for treating allergic disorders
PARKER HUGHES INST107 citations98
US6452005B1Sep 17, 2002
JAK-3 inhibitors for treating allergic disorders
PARKER HUGHES INST26 citations96
US6495556B2Dec 17, 2002
Dimethoxy quinazolines for treating diabetes
PARKER HUGHES INST44 citations95
US6469013B2Oct 22, 2002
Therapeutic compounds
PARKER HUGHES INST51 citations95
US6248790B1Jun 19, 2001
Treatment of inflammation with 2,4,6-trihydroxy-alpha-rho-methoxyphenylacetophenone, or its pharmaceutically acceptable derivatives
PARKER HUGHES INST40 citations92
US6391921B2May 21, 2002
Treatment of inflammation with 2,4,6-trihydroxy-α-para-methoxyphenylacetophenone, or its pharmaceutically acceptable derivatives
PARKER HUGHES INST1 citations52
JANSSEN BIOTECH INC
6 patentsUS9212227B2Dec 15, 2015
ST2L antibody antagonists for the treatment of ST2L-mediated inflammatory pulmonary conditions
JANSSEN BIOTECH INC13 citations91
US9090694B2Jul 28, 2015
ST2L antibody antagonists
JANSSEN BIOTECH INC19 citations91
US9951137B2Apr 24, 2018
ST2L antagonists and methods of use
JANSSEN BIOTECH INC4 citations82
US10450377B2Oct 22, 2019
ST2L antagonists and methods of use
JANSSEN BIOTECH INC1 citations71
US11746161B2Sep 5, 2023
Antibodies that specifically bind PD-1 and methods of use
JANSSEN BIOTECH INC3 citations68
US10995149B2May 4, 2021
Antibodies that specifically bind PD-1 and methods of use
JANSSEN BIOTECH INC2 citations68